Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Factors Associated With Aspirin Failure in Preeclampsia Prevention
NCT05709483Phase 1Recruiting
- Sponsor
- The Rockefeller University
- Start
- Apr 2023
- Primary completion
- Nov 2026
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 1, open-label trial of aspirin in preeclampsia (2 arms), sponsored by The Rockefeller University. Primary endpoint: Allelic frequency of the PAR4 variant (rs773902). Started Apr 2023; status: recruiting.
02
Drugs
aspirin
03
Conditions
preeclampsia
Beyond the preview
Go deeper on NCT05709483.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05709483.